Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2016

Mar 3, 2016

29777_dirs_2016-03-02_ed3026ff-a6b2-49f9-a1a1-c06de9fc51f3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-02-29

Reporting Person: Fussell Stephen R (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-29 Common shares without par value F 10039 $39.52 Disposed 156369 Direct
2016-02-29 Common shares without par value S 62 $39.265 Disposed 156307 Direct
2016-02-29 Common shares without par value S 1340 $39.261 Disposed 154967 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 1395 Indirect
Common shares without par value 53 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 29, 2016.

F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.